» Articles » PMID: 39070247

Time Course of High-Energy Phosphate Depletion During Cold Storage of Human Heart Grafts Using the Celsior Solution

Overview
Journal Transpl Int
Specialty General Surgery
Date 2024 Jul 29
PMID 39070247
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to provide insight into high-energy phosphate compound concentration dynamics under realistic clinical cold-storage conditions using the Celsior solution in seven heart grafts discarded from transplantation. The hearts of seven local donors (three males, four females, age 37 ± 17 years, height 175 ± 5 cm, weight 75 ± 9 kg) initially considered for transplantation and eventually discarded were submitted to a Magnetic Resonance Spectroscopy observation in a clinical Magnetic Resonance Imaging scanner over at least 9 h. The grafts remained in their sterile container at 4°C during the entire examination. Hence, Phosphocreatine (PCr), adenosine triphosphate (ATP), inorganic phosphate (Pi) and intracellular pH were recorded non-destructively at a 30-minute interval. With the ischemic time Ti, the concentration ratios decreased at PCr/ATP = 1.68-0.0028·Tis, Pi/ATP = 1.38 + 0.0029·Tis, and intracellular pH at 7.43-0.0012·Tis. ATP concentration remained stable for at least 9 h and did not decrease as long as phosphocreatine was detectable. Acidosis remained moderate. In addition to the standard parameters assessed at the time of retrieval, Magnetic Resonance Spectroscopy can provide an assesment of the metabolic status of heart grafts before transplantation. These results show how HEPC metabolites deplete during cold storage. Although many parameters determine graft quality during cold storage, the dynamics of HEPC and intracellular pH may be helpful in the development of strategies aiming at extending the ischemic time.

References
1.
Bona M, Wyss R, Arnold M, Mendez-Carmona N, Sanz M, Gunsch D . Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers. J Am Heart Assoc. 2021; 10(4):e018966. PMC: 7955334. DOI: 10.1161/JAHA.120.018966. View

2.
Menasche P, Termignon J, Pradier F, GROUSSET C, Mouas C, Alberici G . Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 1994; 8(4):207-13. DOI: 10.1016/1010-7940(94)90117-1. View

3.
Bernard M, Menasche P, Canioni P, Fontanarava E, GROUSSET C, PIWNICA A . Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates. J Thorac Cardiovasc Surg. 1985; 90(2):235-42. View

4.
Kober F, Caus T, Riberi A, Confort-Gouny S, Lefur Y, Izquierdo M . Objective and noninvasive metabolic characterization of donor hearts by phosphorous-31 magnetic resonance spectroscopy. Transplantation. 2002; 74(12):1752-6. DOI: 10.1097/00007890-200212270-00018. View

5.
Cobert M, Merritt M, West L, Ayers C, Jessen M, Peltz M . Metabolic characteristics of human hearts preserved for 12 hours by static storage, antegrade perfusion, or retrograde coronary sinus perfusion. J Thorac Cardiovasc Surg. 2014; 148(5):2310-2315.e1. PMC: 4126897. DOI: 10.1016/j.jtcvs.2014.02.023. View